AMD3465

AMD3465

Stock Code: 3574902
Manufacturer Part No: SML1433-5MG
Order Now for 7 day delivery
£164.36 (exc VAT) per 5MG
Quantity: - +

Biochem/physiol Actions


AMD3465 is also termed as{N-[1,4,8,11-tetraazacyclotetradecanyl-1,4-phenylenebis(methylene)]-2-(aminomethyl)pyridine}. It controls oncogenic signaling and invasiveness in vitro. It inhibits breast cancer growth and metastasis in vivo. As a chemokine receptor 4 (CXCR4) antagonist, AMD3465 is ten times more efficient than bicyclam AMD3100.


AMD3465 is a highly selective chemokine receptor CXCR4 antagonist with antiviral and anticancer activity. The chemokine receptor CXCR4 is expressed on a wide variety of leukocytes and is the predominant receptor for stromal cell-derived factor-1 (SDF1, CXCL12) in addition to acting as a co-receptor for HIV entry into cells. AMD3465 blocks surface binding of CXCL12 (SDF-1α). AMD3465 is an antagonist of SDF-1 ligand binding (K(i) of 41.7+/-1.2 nM). AMD3465 was found to halt the progression of an agressive childhood blood cancer, T-cell acute lymphoblastic leukemia (T-ALL), within two weeks of starting treatment in an animal model.


Packaging


5, 25 mg in glass bottle

Colourwhite to light brown
Quality Level100
InChI keyCWJJHESJXJQCJA-UHFFFAOYSA-N
InChI1S/C24H38N6/c1-2-13-29-24(5-1)20-28-19-22-6-8-23(9-7-22)21-30-17-4-12-26-15-14-25-10-3-11-27-16-18-30/h1-2,5-9,13,25-28H,3-4,10-12,14-21H2
ManufacturerSIGMA-ALDRICH
SolubilityH2O: 25 mg/mL, clear
Formpowder
Assay≥98% (HPLC)

There are no downloads for this product.